Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2021

Every FDA drug recall initiated in 2021, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,152 recalls, newest first.

Class I · High risk

NovoLog (Insulin aspart)

Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.

Terminated Temperature excursion Novo Nordisk Inc NDC 0169-7501-90 D-0616-2021
Class I · High risk

NovoLog FlexPen

Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.

Terminated Temperature excursion Novo Nordisk Inc NDC 0169-6339-90 D-0615-2021
Class I · High risk

Levemir FlexTouch

Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.

Terminated Temperature excursion Novo Nordisk Inc NDC 0169-6438-90 D-0614-2021
Class I · High risk

Fiasp (insulin aspart injection)

Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.

Terminated Temperature excursion Novo Nordisk Inc NDC 0169-3201-90 D-0613-2021
Class I · High risk

Fiasp PenFill

Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.

Terminated Temperature excursion Novo Nordisk Inc NDC 0169-3205-91 D-0612-2021
Class I · High risk

Fiasp FlexTouch

Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.

Terminated Temperature excursion Novo Nordisk Inc NDC 0169-3204-90 D-0611-2021
Class II · Moderate risk

ChloraPrep With Tint 2% w/v chlorhexidine gluconate

CGMP Deviations: Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity.

Terminated Labeling / mix-up CareFusion 213, LLC D-0350-2021
Class II · Moderate risk

ChloraPrep One-Step 2% w/v chlorhexidine gluconate

CGMP Deviations: Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity.

Terminated Labeling / mix-up CareFusion 213, LLC D-0349-2021
Class II · Moderate risk

BD ChloraPrep Hi-Lite Orange 2% w/v chlorhexidine gluconate

Lack of Assurance of Sterility: Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity.

Terminated Sterility / contamination CareFusion 213, LLC NDC 54365-400-33 D-0348-2021
Class II · Moderate risk

BD ChloraPrep Clear

Lack of Assurance of Sterility: Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, there is the potential for growth of Aspergillus penicillioides, a type of fungus, resulting in a breach of the package integrity.

Terminated Sterility / contamination CareFusion 213, LLC NDC 54365-400-32 D-0347-2021
Class I · High risk

ChloraPrep With Tint 2% w/v chlorhexidine gluconate

Microbial Contamination of Non-Sterile Product:.Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, growth of Aspergillus penicillioides, a type of fungus, resulted in a breach of the package integrity.

Terminated Microbial contamination CareFusion 213, LLC D-0346-2021
Class I · High risk

ChloraPrep One-Step 2% w/v chlorhexidine gluconate

Microbial Contamination of Non-Sterile Product.Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, growth of Aspergillus penicillioides, a type of fungus, resulted in a breach of the package integrity.

Terminated Microbial contamination CareFusion 213, LLC D-0345-2021
Class I · High risk

BD ChloraPrep Clear

Non-sterility.Product is being recalled because at labeled storage conditions of 30*C/75% Relative Humidity, growth of Aspergillus penicillioides, a type of fungus, resulted in a breach of the package integrity.

Terminated Sterility / contamination CareFusion 213, LLC NDC 54365-400-32 D-0343-2021
Class III · Low risk

Distributed by: DocRx

Labeling: Illegible label: Manufacturer received complaint of mis-alignment print of the printed dosing instructions on the blister card.

Ongoing Labeling / mix-up Asclemed USA Inc. dba Enovachem Pharmaceuticals D-0330-2021
Class II · Moderate risk

Neomycin Sulfate Tablets

Failed Stability Specifications: Out of Specification (OOS) result reported for microbiological assay

Terminated Stability / shelf life X-Gen Pharmaceuticals Inc. NDC 39822-0310-5 D-0328-2021
Class II · Moderate risk

Omeprazole Delayed Release Capsules

Failed Impurities/Degradation Specifications: Out of Specification results obtained for unknown impurities during stability testing by manufacturer

Terminated Impurity / degradation Golden State Medical Supply Inc. NDC 51407-129-10 D-0312-2021
Class III · Low risk

Lcl-2-0191

An error occurred where the product was manufactured with Potassium Chloride instead of Potassium Phosphate.

Terminated Other Washington Homeopathic Products, Inc. D-0323-2021
Class III · Low risk

Sp-4

An error occurred where the product was manufactured with Potassium Chloride instead of Potassium Phosphate.

Terminated Other Washington Homeopathic Products, Inc. D-0322-2021
Class III · Low risk

Macula Pellets Homeopathic Medicine

An error occurred where the product was manufactured with Potassium Chloride instead of Potassium Phosphate.

Terminated Other Washington Homeopathic Products, Inc. NDC 58770-190-42 D-0321-2021
Class II · Moderate risk

Brompheniramine Maleate

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 60432-275-16 D-0596-2021

Recalls by year